Bausch + Lomb IPO: Should You Invest?

The U.S. initial-public-offering market is bracing for what is expected to be the second-biggest deal of the year so far this week, that of eyecare company #BauschLomb, which is expected to raise up to $840 million at a valuation of more than $8 billion.

Bausch+Lomb is offering 35 million shares priced at $21 to $24 each. With 350,000 shares expected to be outstanding after the offering, the company would be valued at $8.4 billion at the top end of the price range.